Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
Clinical trial NCT04829097 · UNKNOWN
Trial details
- NCT number
- NCT04829097
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2023-11-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.